The SARS-Cov-2 Proliferation Blocked by a Novel and Potent Main Protease Inhibitor via Computer-aided Drug Design

The recent prevalence of novel “coronavirus disease 2019” has expanded quickly globally, causing a universal pandemic. Herein, an effort was constructed to design a potent drug to inhibit the main protease of SARS-Cov-2 (3CLp) by means of structure-based drug design. A large library of the compounds...

Descripción completa

Detalles Bibliográficos
Autores principales: Shayan, Sepideh, Jamaran, Shahab, Askandar, Rafee Habib, Rahimi, Arian, Elahi, Azam, Farshadfar, Chiako, Ardalan, Noeman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shaheed Beheshti University of Medical Sciences 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653640/
https://www.ncbi.nlm.nih.gov/pubmed/34903997
http://dx.doi.org/10.22037/ijpr.2021.114846.15061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653640/
https://www.ncbi.nlm.nih.gov/pubmed/34903997
http://dx.doi.org/10.22037/ijpr.2021.114846.15061

Ejemplares similares